Methodologies for critical appraisal of prevalence studies: a systematic review

ID: 

156

Session: 

Poster session 1

Date: 

Sunday 16 September 2018 - 12:30 to 14:00

All authors in correct order:

Migliavaca CB1, Stein C1, Colpani V1, Falavigna M1
1 Hospital Moinhos de Vento, Brazil
Presenting author and contact person

Presenting author:

Maicon Falavigna

Contact person:

Abstract text
Background: Prevalence estimates have an important role in public health, supporting decisions related to health policies. Despite their importance, and considering that systematic reviews of prevalence studies have been increasingly published in the literature, there is still uncertainty and lack of standards for quality assessment of these studies.

Objectives: To identify, characterize and compare tools and frameworks used to assess the methodological quality of prevalence studies.

Methods: We searched MEDLINE, Embase and Web of Science from inception to January 2018 using terms related to 'prevalence' and 'critical appraisal'. We also screened the reference lists of included articles, contacted experts in the field and searched for further instruments on Google Scholar and websites of relevant institutions. We included methodological studies, manuals and handbooks that described a methodology (e.g. questionnaires, checklists, frameworks) to appraise prevalence studies critically. For each methodology identified, we extracted information about development, validation, applicability, content and design. Two reviewers performed study selection and data abstraction independently. PROSPERO registration number CRD42018088437.

Results: The search resulted in 2361 abstracts. After excluding duplicates, we screened 1315 titles and abstracts and are currently assessing 34 full-text articles for inclusion. Results will be presented descriptively, and the main characteristics of identified methodologies will be summarized into tabular form. Complete results will be presented at the Colloquium.

Conclusions: With this systematic review, we expect to provide useful information about how the quality of evidence for prevalence studies may be assessed in order to inform policy makers for healthcare decision-making better.

Patient or healthcare consumer involvement: It is of critical importance for public health and healthcare consumers because of its impact on health system policies and priority-setting definition.

Attachments: 

Relevance to patients and consumers: 

Prevalence is an epidemiological measure representing the frequency of a health condition. It is of critical importance for public health and healthcare consumers because of its impact on health system policies and priority-setting definition. Despite the increase in studies providing prevalence estimates in the literature, the assessment of the accuracy of these estimates is often neglected and there is uncertainty about how to conduct this assessment. With our work, we expect to provide important insights into how to assess the quality of prevalence studies. In this way, health-related decision-making can be based on better judgement.